Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial
Titel:
Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial
Auteur:
Venter, Willem D F Moorhouse, Michelle Sokhela, Simiso Serenata, Celicia Akpomiemie, Godspower Qavi, Ambar Mashabane, Nonkululeko Arulappan, Natasha Sim, Joel W Sinxadi, Phumla Z Wiesner, Lubbe Maharaj, Ellisha Wallis, Carole Boyles, Tom Ripin, David Stacey, Sarah Chitauri, Gila Hill, Andrew